article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

article thumbnail

Virtual Reality Training For Medical Device Sales Reps With David Howe

Evolve Your Success

In this episode, Samuel Adeyinka interviews David Howe to explore the world of virtual reality training for medical device sales reps. We are a virtual reality surgical training and assessment platform. I like to describe this in terms of the state of medical education and medical device sales training.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine

Pharmaceutical Technology

It initially targeted seven serotypes, before Pfizer launched an updated version that targeted 13 serotypes in 2010. The post Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine appeared first on Pharmaceutical Technology.

article thumbnail

Improving Patient Outcomes with Immersive Learning

Infuse Medical

Infuse Medical’s proficiency in 3D animation and VR technologies enables the development of highly immersive and technically advanced simulations that are relevant and interactive for medical training. In aviation, pilots can train for emergency situations within a realistic flight simulator.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 91
article thumbnail

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

European Pharmaceutical Review

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 88
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

She has a background in Biomedical Science and has trained in Epidemiology, gaining an MSc from The London School of Hygiene & Tropical Medicine (LSHTM), and holds a PgD in Pharmacovigilance. EMA/95098/2010. Samantha leads study design and statistical analysis and has experience with the CPRD electronic health records database.

Safety 112